58 related articles for article (PubMed ID: 25436678)
1. From tissue invasion to glucose metabolism: the many aspects of signal transducer and activator of transcription 3 pro-oncogenic activities.
Pensa S; Demaria M; Avalle L; Barbieri I; Camporeale A; Poli V
Horm Mol Biol Clin Investig; 2012 Jun; 10(1):217-25. PubMed ID: 25436678
[TBL] [Abstract][Full Text] [Related]
2. Constitutively active Stat3 enhances neu-mediated migration and metastasis in mammary tumors via upregulation of Cten.
Barbieri I; Pensa S; Pannellini T; Quaglino E; Maritano D; Demaria M; Voster A; Turkson J; Cavallo F; Watson CJ; Provero P; Musiani P; Poli V
Cancer Res; 2010 Mar; 70(6):2558-67. PubMed ID: 20215508
[TBL] [Abstract][Full Text] [Related]
3. STAT3 can serve as a hit in the process of malignant transformation of primary cells.
Demaria M; Misale S; Giorgi C; Miano V; Camporeale A; Campisi J; Pinton P; Poli V
Cell Death Differ; 2012 Aug; 19(8):1390-7. PubMed ID: 22402588
[TBL] [Abstract][Full Text] [Related]
4. A STAT3-mediated metabolic switch is involved in tumour transformation and STAT3 addiction.
Demaria M; Giorgi C; Lebiedzinska M; Esposito G; D'Angeli L; Bartoli A; Gough DJ; Turkson J; Levy DE; Watson CJ; Wieckowski MR; Provero P; Pinton P; Poli V
Aging (Albany NY); 2010 Nov; 2(11):823-42. PubMed ID: 21084727
[TBL] [Abstract][Full Text] [Related]
5. STAT3 Activities and Energy Metabolism: Dangerous Liaisons.
Camporeale A; Demaria M; Monteleone E; Giorgi C; Wieckowski MR; Pinton P; Poli V
Cancers (Basel); 2014 Jul; 6(3):1579-96. PubMed ID: 25089666
[TBL] [Abstract][Full Text] [Related]
6. Stat3 is required for anchorage-independent growth and metastasis but not for mammary tumor development downstream of the ErbB-2 oncogene.
Barbieri I; Quaglino E; Maritano D; Pannellini T; Riera L; Cavallo F; Forni G; Musiani P; Chiarle R; Poli V
Mol Carcinog; 2010 Feb; 49(2):114-20. PubMed ID: 20027636
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3.
Leslie K; Lang C; Devgan G; Azare J; Berishaj M; Gerald W; Kim YB; Paz K; Darnell JE; Albanese C; Sakamaki T; Pestell R; Bromberg J
Cancer Res; 2006 Mar; 66(5):2544-52. PubMed ID: 16510571
[TBL] [Abstract][Full Text] [Related]
8. An RNA-binding protein alphaCP-1 is involved in the STAT3-mediated suppression of NF-kappaB transcriptional activity.
Nishinakamura H; Minoda Y; Saeki K; Koga K; Takaesu G; Onodera M; Yoshimura A; Kobayashi T
Int Immunol; 2007 May; 19(5):609-19. PubMed ID: 17383969
[TBL] [Abstract][Full Text] [Related]
9. STAT3 and MITF cooperatively induce cellular transformation through upregulation of c-fos expression.
Joo A; Aburatani H; Morii E; Iba H; Yoshimura A
Oncogene; 2004 Jan; 23(3):726-34. PubMed ID: 14737107
[TBL] [Abstract][Full Text] [Related]
10. The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis.
Rosen DG; Mercado-Uribe I; Yang G; Bast RC; Amin HM; Lai R; Liu J
Cancer; 2006 Dec; 107(11):2730-40. PubMed ID: 17063503
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic effects of signal transducer and activator of transcription 3 siRNA on human breast cancer in xenograft mice.
Yang Z; Cai JH; Xie SJ; Li GX; Song WQ; Yan QH; Yan L; Zhang F
Chin Med J (Engl); 2011 Jun; 124(12):1854-61. PubMed ID: 21740845
[TBL] [Abstract][Full Text] [Related]
12. Disruption of STAT3 signaling leads to tumor cell invasion through alterations of homotypic cell-cell adhesion complexes.
Rivat C; De Wever O; Bruyneel E; Mareel M; Gespach C; Attoub S
Oncogene; 2004 Apr; 23(19):3317-27. PubMed ID: 15077188
[TBL] [Abstract][Full Text] [Related]
13. Signal transducers and activators of transcription-3 up-regulates tissue inhibitor of metalloproteinase-1 expression and decreases invasiveness of breast cancer.
Dien J; Amin HM; Chiu N; Wong W; Frantz C; Chiu B; Mackey JR; Lai R
Am J Pathol; 2006 Aug; 169(2):633-42. PubMed ID: 16877361
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
Li WC; Ye SL; Sun RX; Liu YK; Tang ZY; Kim Y; Karras JG; Zhang H
Clin Cancer Res; 2006 Dec; 12(23):7140-8. PubMed ID: 17145839
[TBL] [Abstract][Full Text] [Related]
15. A perylene derivative regulates HIF-1α and Stat3 signaling pathways.
Chen H; Guan Y; Yuan G; Zhang Q; Jing N
Bioorg Med Chem; 2014 Feb; 22(4):1496-505. PubMed ID: 24485121
[TBL] [Abstract][Full Text] [Related]
16. Deregulated NFATc1 activity transforms murine fibroblasts via an autocrine growth factor-mediated Stat3-dependent pathway.
Lagunas L; Clipstone NA
J Cell Biochem; 2009 Sep; 108(1):237-48. PubMed ID: 19565565
[TBL] [Abstract][Full Text] [Related]
17. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis.
Niu G; Wright KL; Huang M; Song L; Haura E; Turkson J; Zhang S; Wang T; Sinibaldi D; Coppola D; Heller R; Ellis LM; Karras J; Bromberg J; Pardoll D; Jove R; Yu H
Oncogene; 2002 Mar; 21(13):2000-8. PubMed ID: 11960372
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of potential Stat3-regulated genes in human breast cancer.
Hsieh FC; Cheng G; Lin J
Biochem Biophys Res Commun; 2005 Sep; 335(2):292-9. PubMed ID: 16081048
[TBL] [Abstract][Full Text] [Related]
19. Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1.
Rajendran P; Li F; Shanmugam MK; Vali S; Abbasi T; Kapoor S; Ahn KS; Kumar AP; Sethi G
J Cell Physiol; 2012 May; 227(5):2184-95. PubMed ID: 21792937
[TBL] [Abstract][Full Text] [Related]
20. All-trans retinoic acid suppresses Stat3 signaling during skin carcinogenesis.
Syed Z; Cheepala SB; Gill JN; Stein J; Nathan C; Digiovanni J; Batra V; Adegboyega P; Kleiner HE; Clifford JL
Cancer Prev Res (Phila); 2009 Oct; 2(10):903-11. PubMed ID: 19789299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
